Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 19,517 shares at $13.01 ($257K) on 2026-04-07, disclosed to the SEC on 2026-04-09.
Scheduled sale ($257k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.01 | 17,717 | $230K | 89.5% |
| 2 | $15.00 | 1,800 | $27K | 10.5% |
| Total | $13.19 avg | 19,517 | $257K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |